Yasuhiro Furuichi

USPTO Granted Patents = 18 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 43(Granted Patents)

Location History:

Kanagawa, JP (2002 - 2006)
Kamakura, JP (1988 - 2020)

Company Filing History:

7 out of 7

Genecare Research Institute Co., Ltd.

patents

4 out of 4

Agene Research Institute Co., Ltd.

Hoffmann-la Roche Inc.

patents

5. 1 out of 19

Dsm Nutritional Products Inc.

7. 1 out of 832,680

Other

patents

Years Active: 1988-2020

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10548990 - Modified siRNA and pharmaceutical composition (2020-02-04),

2. 8809296 - Apoptosis inducer for cancer cell (2014-08-19),

3. 8703930 - Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes (2014-04-22),

4. 8470798 - Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes (2013-06-25),

5. 8314073 - Cancer-cell-specific cell proliferation inhibitors (2012-11-20),

6. 8299044 - Apoptosis inducer for cancer cell (2012-10-30),

7. 8193332 - Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes (2012-06-05),

8. 7329497 - Gene causative of Rothmund-Thomson syndrome and its gene product (2008-02-12),

9. 7081522 - Gene causative of Rothmund-Thomson syndrome and gene product (2006-07-25),

10. 6955906 - Biotin biosynthetic genes having biotin synthase activity (2005-10-18),

11. 6723544 - Biotin biosynthetic genes (2004-04-20),

12. 6544736 - Method for synthesizing cDNA from mRNA sample (2003-04-08),

13. 6472513 - Human gene RecQ4 encoding helicase (2002-10-29),

14. 6365388 - Biotin biosynthetic genes (2002-04-02),

15. 6335435 - Human gene RecQ4 encoding helicase (2002-01-01),

Title: Yasuhiro Furuichi: Innovator in Genetic Research

Introduction

Yasuhiro Furuichi is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of genetic research, holding a total of 18 patents. His work focuses on innovative solutions for cancer treatment and genetic engineering.

Latest Patents

Among his latest patents is a modified siRNA and pharmaceutical composition. This invention involves a double-stranded modified siRNA targeting a RecQL1 helicase gene. The sense strand includes specific nucleotide sequences with 2'-substituted nucleotides at various positions. Another notable patent is an apoptosis inducer for cancer cells. This invention reveals that suppressing the expression of certain genes can induce apoptosis in various cancer cells, thereby inhibiting their proliferation.

Career Highlights

Yasuhiro Furuichi has worked with several esteemed organizations, including Genecare Research Institute Co., Ltd. and Agene Research Institute Co., Ltd. His research has paved the way for advancements in cancer therapies and genetic modifications.

Collaborations

He has collaborated with notable colleagues such as Akira Shimamoto and Motoki Takagi. Their combined efforts have contributed to the success of various research projects and innovations in the field.

Conclusion

Yasuhiro Furuichi's work exemplifies the impact of innovative research in genetics and cancer treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.